Serum glycobiomarkers for chronic inflammatory demyelinating polyneuropathy. [PDF]
Furukawa S +12 more
europepmc +1 more source
Humoral Immune Response Following COVID-19 Vaccination in Multifocal Motor Neuropathy and Chronic Inflammatory Demyelinating Polyneuropathy. [PDF]
Kodal LS +18 more
europepmc +1 more source
Chronic inflammatory demyelinating polyneuropathy complicated by pre-eclampsia progressing to HELLP syndrome and pulmonary embolism: A case report. [PDF]
Herman M +3 more
europepmc +1 more source
Eculizumab as a Disease-Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Case Report. [PDF]
Schilke ED +12 more
europepmc +1 more source
Comparison of imaging markers of nerve ultrasound and MR-neurography in a longitudinal course in chronic inflammatory demyelinating polyneuropathy. [PDF]
Lüling B +17 more
europepmc +1 more source
Unique Nerve Tissue-Restricted T-Cell Clones in Chronic Inflammatory Demyelinating Polyneuropathy. [PDF]
van Lieverloo GGA +8 more
europepmc +1 more source
Inverse relation between serum neurofilament light chain and cognitive function in chronic inflammatory demyelinating polyneuropathy. [PDF]
Geran R +4 more
europepmc +1 more source
An auxiliary diagnostic strategy for distinguishing Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: combining platelet-to-lymphocyte ratio and cerebrospinal fluid interleukin-8 levels. [PDF]
Song S +9 more
europepmc +1 more source
Syncope and New-Onset Bifascicular Block Associated With Intravenous Immunoglobulin in a Patient With Chronic Inflammatory Demyelinating Polyneuropathy. [PDF]
Wolchover T +4 more
europepmc +1 more source
Efficacy, Safety, and Tolerability of Subcutaneous Efgartigimod PH20 in Chinese Patients With Chronic Inflammatory Demyelinating Polyneuropathy: A Prespecified Subpopulation Analysis of the Multicentre, Randomised-Withdrawal, Double-Blind, Placebo-Controlled, Phase II ADHERE Trial. [PDF]
Lin J +30 more
europepmc +1 more source

